Delta Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.12M Sell
935
-3,816
-80% -$3.9M 0.8% 25
2026
Q1
$4.37M Buy
4,751
+3,699
+352% +$3.75M 3.33% 13
2025
Q4
$1.13M Buy
1,052
+8
+0.8% +$7.65K 0.95% 24
2025
Q3
$797K Buy
1,044
+5
+0.5% +$3.72K 0.62% 25
2025
Q2
$810K Hold
1,039
0.68% 24
2025
Q1
$858K Sell
1,039
-81
-7% -$67.4K 0.78% 19
2024
Q4
$865K Hold
1,120
0.81% 19
2024
Q3
$992K Hold
1,120
0.95% 19
2024
Q2
$1.01M Hold
1,120
0.99% 19
2024
Q1
$871K Buy
+1,120
New +$797K 0.9% 24

Other funds holding LLY

Delta Wealth Advisors's LLY Position: Q2 2026 in Review

Delta Wealth Advisors reduced its Eli Lilly (LLY) stake by 80% in Q2 2026, selling an estimated $3.9M and leaving 935 shares worth $1.12M. The position accounts for 0.8% of the portfolio, ranked #25.

Delta Wealth Advisors first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $4.37M in Q1 2026. 1,654 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Delta Wealth Advisors held 935 shares of Eli Lilly worth $1.12M as of Q2 2026.
  • Delta Wealth Advisors sold 3,816 Eli Lilly shares in Q2 2026, an estimated $3.9M.
  • Eli Lilly made up 0.8% of Delta Wealth Advisors's portfolio in Q2 2026, its #25 holding.
  • Delta Wealth Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • Delta Wealth Advisors's Eli Lilly position peaked at $4.37M in Q1 2026.
  • 1,654 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Delta Wealth Advisors's 13F filing for Q2 2026, filed 14 Jul 2026.